SCHEMBL15977834

SCHEMBL15977834

c1cncc(-c2ccc(-c3ccc4c(-c5ccc(-c6ccc7ccccc7c6)cc5)c5ccccc5c(-c5ccc(-c6ccc7ccccc7c6)cc5)c4c3)nc2)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 11/20 0.59
CYP11B1 P15538 11/20 0.59
CYP19A1 P11511 7/20 0.59
CYP17A1 P05093 4/20 0.59
CYP2A6 P11509 1/20 0.46
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HSD17B1 P14061 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B2 P37059 1/20 0.41
ERN1 O75460 1/20 0.41
DHODH Q02127 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977518 0.98 CYP11B2 (0.59) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL15977600 0.95 CYP11B2 (0.56) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL15977824 0.95 CYP11B2 (0.56) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL15977828 0.95 CYP11B2 (0.58) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL15977725 0.94 CYP11B2 (0.58) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL15977585 0.94 CYP11B2 (0.58) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL13658730 0.94 CYP11B2 (0.61) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL10030070 0.91 CYP11B2 (0.71) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL15977741 0.90 CYP11B1 (0.44) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL15977539 0.90 CYP11B1 (0.47) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP11B2 1585/4885CYP11B1 1241/4885CYP19A1 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.